Levetiracetam Liderfarm (Levetiracetam)

Levetiracetam works by binding to the synaptic vesicle protein SV2A, which plays a key role in the regulation of neurotransmitter release. This binding modulates calcium‑dependent exocytosis, stabilizing neuronal membranes and decreasing excessive neuronal firing, thereby lowering the likelihood of seizure initiation and spread.

The dosage of Levetiracetam Liderfarm is individualized and determined by the prescribing clinician based on the patient’s age, weight, renal function, and seizure type. Healthcare providers titrate the dose to achieve optimal seizure control while minimizing side effects, and patients should follow the prescriber’s instructions precisely.

Safety data for levetiracetam in pregnancy and lactation are limited. Clinicians must weigh the potential benefits of seizure control against any possible risks to the fetus or infant. If treatment is necessary, the prescriber may continue therapy with close monitoring, and breastfeeding decisions should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

Levetiracetam offers a favorable safety profile and minimal drug‑enzyme interactions compared with many older antiepileptics such as carbamazepine or phenytoin. It does not require routine therapeutic drug monitoring and is generally well tolerated, though clinicians still monitor for mood changes. Its rapid absorption and linear pharmacokinetics make dosing straightforward, but individual response varies.

Levetiracetam Liderfarm tablets should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging to protect it from moisture and light. Do not store in a bathroom or near heat sources, and keep out of reach of children.

Levetiracetam Liderfarm is taken orally, usually with or without food, as directed by the prescriber. Tablets are swallowed whole with a glass of water. The dosing schedule (once, twice, or three times daily) depends on the individual treatment plan and should be followed exactly as prescribed.

Serious risks include severe allergic reactions (such as rash, swelling, or breathing difficulty), significant mood alterations including depression, anxiety, or suicidal thoughts, and rare hematologic abnormalities like neutropenia or thrombocytopenia. Patients should seek immediate medical attention if they experience any of these symptoms.

Levetiracetam is contraindicated in individuals with known hypersensitivity to levetiracetam or any of its excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric disorders, or those taking interacting medications that may reduce its efficacy. The prescriber will assess suitability before initiating therapy.